Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients - Concepedia

Concepedia

Publication | Closed Access

Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients

50

Citations

30

References

2014

Year

Céline Narjoz, Anatole Cessot, Audrey Thomas‐Schoemann, Jean Louis Golmard, Olivier Huillard, Pascaline Boudou‐Rouquette, Alexandre Béhouche, Fabrice Taïeb, Jean-Philippe Durand, A. Dauphin,

Investigational New Drugs

OncologyMedicinePharmacogenetic VariantsPharmacotherapyAnti-cancer AgentCancer PatientsCancer TreatmentPharmacologyCancer ResearchLean Body Mass

References

	Year	Citations

Page 1

Page 1